Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Clin Obstet Gynecol ; 55(3): 838-48, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22828115

ABSTRACT

Pregnancy represents a unique opportunity to screen reproductive age women for cervical cancer and abnormal cervical cytology is relatively common in this population. In the absence of large, prospective clinical trials investigating the optimal management strategies for cervical dysplasia in pregnant women, consensus guidelines established by the American Society for Colposcopy and Cervical Pathology is available with considerations to this special patient population. Modalities for evaluation and management algorithms are reviewed and summarized from largely case series of pregnant women with cervical dysplasia and cervical cancer.


Subject(s)
Pregnancy Complications, Neoplastic , Uterine Cervical Neoplasms , Biopsy , Cervix Uteri/pathology , Colposcopy , Female , Humans , Neoplasm Staging , Papanicolaou Test , Papillomavirus Infections/diagnosis , Papillomavirus Infections/pathology , Papillomavirus Infections/therapy , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/pathology , Pregnancy Complications, Infectious/therapy , Pregnancy Complications, Neoplastic/diagnosis , Pregnancy Complications, Neoplastic/pathology , Pregnancy Complications, Neoplastic/therapy , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/therapy , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/therapy , Vaginal Smears
2.
Fam Cancer ; 10(3): 535-43, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21538078

ABSTRACT

Women at risk for Lynch Syndrome/HNPCC have an increased lifetime risk of endometrial and ovarian cancer. This study investigates the cost-effectiveness of prophylactic surgery versus surveillance in women with Lynch Syndrome. A decision analytic model was designed incorporating key clinical decisions and existing probabilities, costs, and outcomes from the literature. Clinical forum where risk-reducing surgery and surveillance were considered. A theoretical population of women with Lynch Syndrome at age 30 was used for the analysis. A decision analytic model was designed comparing the health outcomes of prophylactic hysterectomy with bilateral salpingo-oophorectomy at age 30 versus annual gynecologic screening versus annual gynecologic exam. The literature was searched for probabilities of different health outcomes, results of screening modalities, and costs of cancer diagnosis and treatment. Cost-effectiveness expressed in dollars per discounted life-years. Risk-reducing surgery is the least expensive option, costing $23,422 per patient for 25.71 quality-adjusted life-years (QALYs). Annual screening costs $68,392 for 25.17 QALYs; and annual examination without screening costs $100,484 for 24.60 QALYs. Further, because risk-reducing surgery leads to both the lowest costs and the highest number of QALYs, it is a dominant strategy. Risk-reducing surgery is the most cost-effective option from a societal healthcare cost perspective.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/economics , Colorectal Neoplasms, Hereditary Nonpolyposis/surgery , Genital Neoplasms, Female/economics , Genital Neoplasms, Female/prevention & control , Mass Screening/economics , Adult , Aged , Colorectal Neoplasms, Hereditary Nonpolyposis/complications , Cost-Benefit Analysis , Female , Follow-Up Studies , Genetic Predisposition to Disease , Genetic Testing , Genital Neoplasms, Female/diagnosis , Genital Neoplasms, Female/etiology , Humans , Middle Aged , Treatment Outcome , Women
3.
Obstet Gynecol ; 110(1): 18-25, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17601891

ABSTRACT

OBJECTIVE: Women from Lynch syndrome/hereditary nonpolyposis colorectal cancer (Lynch/HNPCC) families have an increased lifetime risk of developing endometrial and ovarian cancer. This study models a comparison of management strategies for women who carry a Lynch/HNPCC mutation. METHODS: A decision analytic model with three arms was designed to compare annual gynecologic examinations with annual screening (ultrasonography, endometrial biopsy, CA 125) and with hysterectomy with bilateral salpingo-oophorectomy at age 30 years The existing literature was searched for studies on the accuracy of endometrial and ovarian cancer screening using endometrial biopsy, transvaginal ultrasonography, and serum CA 125. The Surveillance, Epidemiology and End Results database from 1988 to 2001 was used to estimate cancer mortality outcomes. RESULTS: In the surgical arm, 0.0056% of women were diagnosed with ovarian cancer and 0.0060% of women with endometrial cancer. These numbers increased to 3.7% and 18.4% in women being screened, and 8.3% and 48.7% in women undergoing annual examinations, respectively. Surgical management led to the longest expected survival time at 79.98 years, followed by screening at 79.31 years, and annual examinations at 77.41 years. If starting at age 30 and discounting life years at 3%, surgery still leads to the greatest expected life years. When comparing prophylactic surgery with the screening option, one would need to perform 75 surgeries to save one woman's entire life. For cancer prevention, however, only 28 and 6 prophylactic surgeries would need to be performed to prevent one case of ovarian and endometrial cancer, respectively. CONCLUSION: Risk-reducing hysterectomy and bilateral salpingo-oophorectomy may be considered in women with Lynch/HNPCC to prevent gynecologic cancers and their associated morbidities.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/complications , Decision Support Techniques , Genetic Predisposition to Disease , Genital Neoplasms, Female/prevention & control , Genital Neoplasms, Female/surgery , Hysterectomy , Ovariectomy , Adult , Aged , Aged, 80 and over , Female , Genetic Counseling , Genital Neoplasms, Female/diagnosis , Genital Neoplasms, Female/genetics , Humans , Middle Aged , Physical Examination , Risk Reduction Behavior , Survival Analysis
4.
N Engl J Med ; 354(3): 261-9, 2006 Jan 19.
Article in English | MEDLINE | ID: mdl-16421367

ABSTRACT

BACKGROUND: Women with the Lynch syndrome (hereditary nonpolyposis colorectal cancer) have a 40 to 60 percent lifetime risk of endometrial cancer and a 10 to 12 percent lifetime risk of ovarian cancer. The benefit of prophylactic gynecologic surgery for women with this syndrome has been uncertain. We designed this study to determine the reduction in the risk of gynecologic cancers associated with prophylactic hysterectomy and bilateral salpingo-oophorectomy in women with the Lynch syndrome. METHODS: Three hundred fifteen women with documented germ-line mutations associated with the Lynch syndrome were identified. Women who had undergone prophylactic hysterectomy (61 women) and women who had undergone prophylactic bilateral salpingo-oophorectomy (47 women) were matched with mutation-positive women who had not undergone the procedure in question (210 women for the analysis of endometrial cancer and 223 for the analysis of ovarian cancer). Women who had undergone prophylactic surgery and their matched controls were followed from the date of the surgery until the occurrence of cancer or until the data were censored at the time of the last follow-up visit. RESULTS: There were no occurrences of endometrial, ovarian, or primary peritoneal cancer among the women who had undergone prophylactic surgery. Endometrial cancer was diagnosed in 69 women in the control group (33 percent), for an incidence density of 0.045 per woman-year, yielding a prevented fraction (the proportion of potential new cancers prevented) of 100 percent (95 percent confidence interval, 90 to 100 percent). Ovarian cancer was diagnosed in 12 women in the control group (5 percent), for an incidence density of 0.005 per woman-year, yielding a prevented fraction of 100 percent (95 percent confidence interval, -62 to 100 percent). CONCLUSIONS: These findings suggest that prophylactic hysterectomy with bilateral salpingo-oophorectomy is an effective strategy for preventing endometrial and ovarian cancer in women with the Lynch syndrome.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/surgery , Endometrial Neoplasms/prevention & control , Hysterectomy , Ovarian Neoplasms/prevention & control , Ovariectomy , Adult , Cohort Studies , Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/etiology , Colorectal Neoplasms, Hereditary Nonpolyposis/complications , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Endometrial Neoplasms/epidemiology , Endometrial Neoplasms/etiology , Female , Germ-Line Mutation , Humans , Incidence , Middle Aged , Neoplasm Staging , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/etiology , Peritoneal Neoplasms/epidemiology , Peritoneal Neoplasms/etiology , Peritoneal Neoplasms/prevention & control , Postoperative Complications , Retrospective Studies , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...